| Literature DB >> 23760705 |
Rachel Crowley1, Neil Gittoes.
Abstract
The management of patients with hypercalcaemia should be informed by the patient's symptoms and signs, by the degree of elevation of calcium, by the underlying mechanism by which calcium has been elevated and by the disease process underlying the presentation. Regardless of diagnosis, all significantly hypercalcaemic patients should be rendered euvolaemic before any further and more specific treatment is considered. Highly symptomatic patients and those with a calcium level of > 3.5 mmol represent a medical emergency that requires inpatient treatment.Entities:
Keywords: Hypercalcaemia; bisphosphonates; hyperparathyroidism; malignancy; vitamin D
Mesh:
Substances:
Year: 2013 PMID: 23760705 PMCID: PMC5922675 DOI: 10.7861/clinmedicine.13-3-287
Source DB: PubMed Journal: Clin Med (Lond) ISSN: 1470-2118 Impact factor: 2.659